477
Views
38
Downloads
0
Crossref
N/A
WoS
2
Scopus
N/A
CSCD
Sliver nanoparticles (Ag NPs) are produced industrially and commercially available in recent time. Silver and its nanoparticles are widely applied to consuming medical purposes. Silver nanoparticles are able to resemble cellular components and typical proteins, which helps the nanoparticles to cross natural barriers in human body. For this reason, the current study was designed to investigate the damage caused by silver nanoparticles, especially in liver which is one of the most targeted organs of nanoparticles as a result of their accumulation and damages caused in various aspects such as tissue, functional ability and DNA of liver cells. 30 albino male rats were used for this study and were divided into 3 main groups. The first group represented control and a normal saline solution was given, while the second group was given silver nanoparticles at a concentration of 2 mg/kg of body weight, and the third group was given silver nanoparticles at a concentration of 3 mg/kg of body weight. Each concentration of Ag NPs was dissolved in 3 mL of the normal saline and given directly to the experimental animal's stomach by feeding tube with diameter of 0.6 cm and every day for 10 weeks. The results in the current study showed histopathological change in liver tissue such as large granulomatous lesion with an increase in macrophage numbers, as also shown by necrotic hepatocytes with dilation of sinusoids. The deformation of architecture in the parenchyma appeared in both concentrations. The biochemical parameters investigation in the liver clarified increased level of enzymes accordance with doses of Ag NPs. The damage was identified in DNA of hepatocytes by comet assay and the degree of damage was evident through increasing the numbers of tailed nuclei and in strand breaks of DNA. The reactive oxygen species (ROS) generation had a key role in the events of structural and functional disorders in the liver of experimental animals.
Sliver nanoparticles (Ag NPs) are produced industrially and commercially available in recent time. Silver and its nanoparticles are widely applied to consuming medical purposes. Silver nanoparticles are able to resemble cellular components and typical proteins, which helps the nanoparticles to cross natural barriers in human body. For this reason, the current study was designed to investigate the damage caused by silver nanoparticles, especially in liver which is one of the most targeted organs of nanoparticles as a result of their accumulation and damages caused in various aspects such as tissue, functional ability and DNA of liver cells. 30 albino male rats were used for this study and were divided into 3 main groups. The first group represented control and a normal saline solution was given, while the second group was given silver nanoparticles at a concentration of 2 mg/kg of body weight, and the third group was given silver nanoparticles at a concentration of 3 mg/kg of body weight. Each concentration of Ag NPs was dissolved in 3 mL of the normal saline and given directly to the experimental animal's stomach by feeding tube with diameter of 0.6 cm and every day for 10 weeks. The results in the current study showed histopathological change in liver tissue such as large granulomatous lesion with an increase in macrophage numbers, as also shown by necrotic hepatocytes with dilation of sinusoids. The deformation of architecture in the parenchyma appeared in both concentrations. The biochemical parameters investigation in the liver clarified increased level of enzymes accordance with doses of Ag NPs. The damage was identified in DNA of hepatocytes by comet assay and the degree of damage was evident through increasing the numbers of tailed nuclei and in strand breaks of DNA. The reactive oxygen species (ROS) generation had a key role in the events of structural and functional disorders in the liver of experimental animals.
J.F. Hillyer, R.M. Albrecht, Gastrointestinal per sorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci., 2001, 90: 1927-1936.
K. Dziendzi kowska, J. Gromadzka-Ostowska, A. Lankoff, et al., Time dependent biodistribution and excretion of silver nanoparticles in male wester rats. J. Appl. Toxicol., 2010, 32: 920-928.
M. Walker, D. Parsons, The biological fate of silver ions following the use of silver-containing wound care products - a review. Int. Wound J., 2012.
Z. Wang, N. Li, J. Zhao, et al., CuO nanoparticle interaction with human epithelial cells: cellular uptake location, Export and genotoxicity. Chem. Res. Toxicol., 2012, 25: 1512-1521.
R. De Lima, A.B. Eabra, and N. Duran, Silver nanoparticles: brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J. Appl. Toxicol., 2012, 32: 867-869.
V. Rabolli, L.C. Thomassen, F. Uwambayinema, et al., The cytotoxic activity of amorphous silica nanoparticles is mainly influenced by surface area and not by aggregation. Toxicol. Lett., 2011, 206: 197-203.
S. Fraga, H. Faria, M.E. Soares, et al., Influence of the surface coating on the cytotoxicity, genotoxicity and uptake of gold nanoparticles in human HepG2 cells. J. Appl. Toxical., 2013, 33: 1111-1119.
V. Edwards-Jones, The benefits of silver in hygiene, personal care and health care. Lett. Appl. Microbiol., 2009, 49(2): 147-152.
S.W. Hoven, W.J. Peijnenburg, C.A. Herberts, et al., Nano-silver a review of available data and know Ledge gaps in human and Environmental risk assessment. Nanotoxicology, 2009, 3(2): 109-138.
C. Brandenberger, C. Muhlfeld, Z. Ali, et al., Quantitative evaluation of cellular up-take and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small, 2010, 6: 1669-1678.
J. Skalska, L. Struzynska, Z.D. Makarewie, et al., Toxic effects of silver nanoparticles in mammals dose a risk of neurotoxicity exist. Folianeuropathol., 2015, 53(4): 281-300.
A.H. Baraaj, Histological and physiological effect of Chitocal on liver, some parameters of blood and body weight in male Albino Rats. Magazine of Al-Kufa University for Biology, 2014, 6(1): 1-8.
M. De Boeck, N. Touil, G. De Visscher, et al., Validation and Implementation of an internal standard in comet assay. Mutat. Res., 2000, 469: 181-197.
H.H. Gustafson, D. Holt-Casper, D.W. Grainger, et al., Nanoparticles uptake: The phagocyte problem. Nano. Today, 2015, 10(4): 487-510.
H.I. Herd, K.T. Bartlett, and J.A. Gustafson, Macrophage silica nanoparticle response is phenotypically dependent. Biomaterials, 2015, 53: 574-582.
J.T. Kwon, A.H. Minai-Tehrani, S.K. Wang, et al., Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicological Research, 2012, 28(1): 25-31.
A.L. Monfared, S. Soltani, Effect of silver nanoparticles administration on the liver of rainbow trout (Oncorhynchus mykiss): histological and biochemical studies. European Journal of Experimental Biology, 2013, 3(2): 285-289.
N. Elyamany, H.A. Kholoussi, D.F. Raouf, et al., Nigella sativa and Aloe vera protection against doxorubicin in hepatotoxicity. J. Exp. Appl. Anim. Sci. , 2016, 2(1): 10-22.
A. Singh, T.K. Bhat, and O.P. Sharma, Clinical Biochemistry of Hepatotoxicity. J. Clin. Toxicol. , 2011, 4: 1-19.
E.J. Park, E. Bae, J. Yi, et al., Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environmental Toxicology and Pharmacology, 2010, 30(2): 162-168.
J.H. Lee, Y.S. Kim, K.S. Song, et al., Bio persistence of silver nanoparticles in tissues from Sprague-Dawley rats. Particle and Fiber Toxicology, 2013, 10(1): 1.
P.V. Asharani, M.P. Hande, and L.S. Valiyaveetti, Anti-proliferative activity of silver nanoparticles. BMC Cell Biology, 2009, 10(1): 1.
S. Hackenberg, A. Scherzed, M. Kessler, et al., Silver nanoparticles evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicology Letters, 2011, 201(1): 27-33.
R. Foldbjerg, P. Olesen, M. Hougaard, et al., PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, Apoptosis and necrosis in THP-1 monocytes. Toxicology Letters, 2009, 192(2): 156-162.
R.P. Singh, P. Ramarao, Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles. Toxicology Letters, 2012, 213(2): 249-259.
Y. Xue, S. Zhang, Y. Huang, et al., Acute toxic effects and gender-related biokinetics of silver nanoparticles following an intravenous injection in mice. Journal of Applied Toxicology, 2012, 32(11): 890-899.
R. Hess, L. Jones, and J.J. Schlager, Unique cellular Interaction of silver nanoparticles: size-dependent generation of reaction oxygen species. J. Phys. Chem. B, 2008, 112: 13608-13619.
Y.H. Hsin, C.F. Chen, S. Huang, et al., The apoptotic effect of nano silver is mediated by a ROS-and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T4 Cells. Toxicology Letters, 2008, 179(3): 130-139.
W. Liu, Y. Wu, C. Wang, et al., Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology B, 2010, 4(3): 319-330.
S.H. Kim, J.W. Ko, S.K. Koh, et al., Silver nanoparticles induce apoptotic cell death in cultured cerebral cortical neurons. Molecular & cellular Toxicology, 2014, 10(2): 173-179.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.